GluCare

What GluCare does

GluCare, operating commercially under parent company Metabolic (formerly GluCare.Health), is a Dubai-based hybrid healthcare provider specializing in the diagnosis and long-term management of metabolic conditions including Type 1 and Type 2 diabetes, gestational and pre-diabetes, obesity, thyroid disorders, PCOS/PMOS, hormone imbalances, and pediatric endocrine conditions. Founded in 2019 and headquartered in Jumeirah, Dubai (with MOHAP-licensed operating entity GluCare Integrated Diabetes Center L.L.C.), the company runs physical clinics in Jumeirah and Al Barsha, with a third at Dubai Digital Park announced. Its differentiated offering is a hybrid care model that combines continuous remote monitoring via wearables, AI-supported in-clinic diagnostics, and multidisciplinary clinical teams spanning endocrinology, cardiology, urology, pediatrics, ophthalmology, and dietetics. Published outcomes across 2,310+ patients show an 18.43% reduction in HbA1c, 24.54% reduction in triglycerides, and 11.60% HDL improvement over 12 months, with the company claiming the largest published clinical evidence base for a metabolic care provider in the Middle East.

Revenue is generated primarily through monthly subscription programs (Unlimited Diabetes Subscription, physician-led Weight Loss with GLP-1 protocols including Wegovy Pill and Foundayo/Orforglipron, and Longevity packages), supplemented by per-visit clinical consultations across specialties, an e-commerce storefront at shop.metabolic.health, and insurance-covered services distributed via WhatsApp, phone, and walk-in channels. A Corporate Health Solutions B2B channel is referenced for employee wellness programs. Distribution is anchored by clinic locations plus early-access partnerships with Insulet (Omnipod 5), Medtronic (MiniMed), Novo Nordisk (Wegovy Pill), and Eli Lilly (Foundayo). In February 2026 the company secured a strategic growth capital facility from RAKBANK — its first institutional funding event after years of founder self-funding — earmarked for international expansion to the United Kingdom (London, 1 Knightsbridge) and the United States, positioning Metabolic as the first UAE-based operator to export a technology-enabled metabolic care model internationally.

Name

GluCare

Legal name

GluCare Integrated Diabetes Center L.L.C.

Website

https://glucare.health

Company type

Private

Founded year

2019

Operating status

Operating

Headcount range

51–100 employees

Short description

GluCare (parent: Metabolic) is a Dubai-based hybrid metabolic healthcare provider offering subscription-based diabetes, obesity, thyroid, and longevity management through clinics, wearables, and AI-supported diagnostics, serving individual and corporate patients in the UAE with planned expansion to the UK and US.

Ownership category

akta.pro rank

Product category

Metabolic Disease Management

NAICS

Offices of Physicians (6211), Medical and Diagnostic Laboratories (62151), Other Individual and Family Services (624190)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Misc Health & Allied Services, Nec (8090), Services-Home Health Care Services (8082)

akta.pro primary industry

Diabetes (General) (HLAKADAA)

akta.pro secondary industries

Diabetes Digital Therapeutics & Dose Decision Support (Bolus Calculators) (HLAHAHAJ), Type 1 Diabetes Care (HLAKADAB), Gestational Diabetes (HLAKADAD), Diabetes & Blood Sugar Nutrition Coaching (HSADAFAF), Diabetes Education & Insulin Management (Home-Based) (HSABACAJ)

Keywords

• Metabolic disease management
• Diabetes care programs
• Weight loss programs
• Continuous glucose monitoring
• Preventive health services

Headquarters

HQ city

Jumeira

HQ country

United Arab Emirates

HQ region

Middle East

Offices4 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Diabetes Subscription Program: Recurring subscription program for diabetes management providing ongoing care, monitoring, and support
2. Weight Loss Program: Structured weight loss programs including physician-led protocols with GLP-1 medications and weight loss tech solutions
3. Longevity Programs: Comprehensive longevity packages and programs for preventive health optimization
4. E-commerce / Shop: Online storefront for metabolic health products including weight loss supplies and health products
5. Clinical Services: Individual consultations and treatments across endocrinology, cardiology, urology, pediatrics, and other specialties
6. Insurance and Subscriptions: Services covered by insurance plans with subscription-based ongoing care options

Pricing tiers

Go-to-market motion2 records

Distribution channels6 records

Marketing channels6 records

Core offering

GluCare provides hybrid metabolic disease management combining in-clinic care with continuous remote monitoring via wearables and AI-powered diagnostics. It delivers structured programs for diabetes (Type 1, Type 2, pre-diabetes, gestational), physician-led weight loss using GLP-1 medications, longevity and preventive health, plus specialty services across endocrinology, cardiology, urology, thyroid, women's and pediatric health. Revenue comes from subscription programs, fee-for-service clinical consultations, insurance-covered visits, and an e-commerce shop for metabolic health products.

Product overview

Metabolic operates as a unified healthcare platform offering an integrated portfolio of metabolic health services through its brands GluCare.Health and Zone.Health. The company provides a comprehensive hybrid care model that combines continuous remote monitoring via wearables and AI-powered diagnostics with in-person clinical consultations. The core offerings include diabetes management programs (covering Type 1, Type 2, prediabetes, gestational), weight loss protocols (including GLP-1 medications like Wegovy), preventive health assessments, longevity programs, and specialized services for thyroid disorders, hormone replacement therapy, pediatric endocrinology, cardiology, and urology. Additional services include peptides protocols, physiotherapy, and corporate health solutions. The platform is complemented by subscription programs and is expanding internationally from Dubai to the UAE, UK, and US markets.

Differentiator

Problem solved

Functional benefit

Products and services

• Diabetes Program

Quantifiable outcome

• 18.43% reduction in HbA1c (diabetes marker)
• +8 more outcomes

Named customers1 record

Segments8 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability1 record

Feature4 records

Partnerships

Four partnerships are on record, tiered core and strategic.

• Insulet CorporationcoreTechnology or IntegrationGluCare offers Omnipod 5 tubeless insulin pump therapy in the UAE, the first provider in the region to make this advanced insulin delivery system available. Omnipod 5 automatically adjusts insulin every 5 minutes for optimal diabetes management.
• MedtroniccoreTechnology or IntegrationPartnership for advanced insulin pump therapy in UAE, offering Medtronic MiniMed solutions as part of comprehensive diabetes management options for pediatric and adult patients.
• Novo NordiskstrategicTechnology or IntegrationAmong first in UAE to offer Wegovy Pill (oral GLP-1) through physician-led metabolic health program. Early access provider for Wegovy Pill and other GLP-1 medications including Mounjaro and Wegovy injections.
• Eli LillystrategicTechnology or IntegrationOffers Foundayo (Orforglipron) oral GLP-1 weight loss medication as part of weight loss protocol. Among first in UAE to provide access to innovative GLP-1 medications for weight management.

Scale indicators4 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Virta Health: US digital health company providing clinician-supervised diabetes reversal and metabolic care via telehealth, CGM, and nutrition coaching — the closest analog to GluCare's hybrid model targeting Type 2 diabetes reversal with measurable outcomes.
• Omada Health: US-based virtual-first chronic care company covering diabetes prevention and management, hypertension, and musculoskeletal care via coaching + connected devices — a direct competitor in the digital metabolic disease management category.
• Levels Health: Consumer CGM-focused metabolic health platform offering continuous glucose monitoring with software-driven insights for diabetes and pre-diabetes, comparable to GluCare's wearable-driven monitoring layer.
• Found: US telehealth platform for sustained weight loss using GLP-1 medications paired with coaching — directly comparable to GluCare's Weight Loss Program with Wegovy/Mounjaro/Foundayo.

Broad incumbents

• Noom: Established digital health company offering weight management, diabetes prevention, and behavior-change programs at large scale — overlapping with GluCare's weight loss and metabolic coaching offerings but operating at much greater scale and breadth.
• Hims & Hers Health: Large US digital health platform expanding into weight loss with GLP-1s and chronic conditions — a broad incumbent whose entry into metabolic and weight management creates competitive pressure on GluCare's subscription bundles.

Emerging players

• ZOE: UK-based personalized nutrition and metabolic health company using CGM, gut microbiome testing, and AI — emerging peer in the metabolic insight category that GluCare targets in its London expansion.
• Lifesum: Digital nutrition and calorie-tracking platform with subscription-based healthy eating, weight loss, and intermittent fasting programs — overlapping with GluCare's nutrition coaching and weight management content layer.

Regional players

• Medcare: UAE-based multi-specialty hospital and clinic group owned by Aster DM Healthcare; comparable as a regional provider of endocrinology, diabetes, and weight management services competing for the same Dubai patient base.
• HealthHub Clinics: Dubai-based multi-specialty clinic network under Al-Futtaim offering endocrinology, family medicine, and chronic disease management — direct regional competitor for diabetes and metabolic care patients in the UAE.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/glucare.health
• LinkedInlinkedin.com/company/glucarehealth

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about GluCare